Home

ImmunoPrecise Antibodies Ltd. - Common Stock (IPA)

0.4050
0.00 (0.00%)

Immunoprecise Antibodies Ltd is a biotechnology company that specializes in the development and production of high-quality antibodies and related therapeutics for use in various biomedical applications

The company offers a range of services, including custom antibody production, protein engineering, and diagnostic assay development, catering to the needs of researchers and pharmaceutical companies. With a focus on advancing personalized medicine and supporting drug discovery, Immunoprecise Antibodies aims to provide innovative solutions that enhance the effectiveness of therapeutic treatments across multiple disease areas.

SummaryNewsPress ReleasesChartHistoricalFAQ
Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · March 14, 2025
What's going on in today's after hours sessionchartmill.com
As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · March 13, 2025
There are notable gap-ups and gap-downs in today's session.chartmill.com
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · March 13, 2025
ImmunoPrecise Antibodies: Q2 Earnings Insightsbenzinga.com
Via Benzinga · December 10, 2024
A Preview Of ImmunoPrecise Antibodies's Earningsbenzinga.com
Via Benzinga · December 9, 2024
Earnings Outlook For ImmunoPrecise Antibodiesbenzinga.com
Via Benzinga · March 13, 2024
What's Going On With ImmunoPrecise Stock Thursday?benzinga.com
ImmunoPrecise announced a partnership with a biotechnology giant to develop ADCs and bispecific antibodies for the treatment of cancer.
Via Benzinga · March 13, 2025
These stocks are moving in today's pre-market sessionchartmill.com
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · February 26, 2025
What's Going On With ImmunoPrecise Antibodies Stock Wednesday?benzinga.com
Immunoprecise shares closed higher on Wednesday after the company announced it developed a new class of GLP-1 therapies.
Via Benzinga · January 22, 2025
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Salesbenzinga.com
Via Benzinga · January 22, 2025
Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earningsbenzinga.com
Via Benzinga · January 22, 2025
Earnings Preview For ImmunoPrecise Antibodiesbenzinga.com
Via Benzinga · December 13, 2023
US Stocks Higher; Netflix Profit Beats Estimatesbenzinga.com
Via Benzinga · January 22, 2025
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · January 22, 2025
Earnings Scheduled For December 10, 2024benzinga.com
Via Benzinga · December 10, 2024
EXCLUSIVE: ImmunoPrecise Antibodies' Subsidiary Releases Software With Customizable Interface For AI-Driven Drug Discoverybenzinga.com
ImmunoPrecise Antibodies launches BioStrand's LENSaiAPI software, enhancing AI-driven drug discovery and data integration for healthcare and pharmaceutical industries.
Via Benzinga · June 10, 2024
EXCLUSIVE: Immunoprecise Antibodies and InterSystems Integrate Vector Search With LENSai For AI-Driven Healthcare Applicationsbenzinga.com
Immunoprecise Antibodies partners with InterSystems to integrate Vector Search of IRIS data platform with BioStrand's LENSai for AI-driven healthcare solutions. Revolutionize drug discovery with precise, scalable data analysis.
Via Benzinga · March 28, 2024
IPA Stock Earnings: ImmunoPrecise Antibodies Misses EPS, Beats Revenue for Q3 2024investorplace.com
IPA stock results show that ImmunoPrecise Antibodies missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.
Via InvestorPlace · March 14, 2024
Earnings Scheduled For March 14, 2024benzinga.com
Companies Reporting Before The Bell • Pharming (NASDAQPHAR) is projected to report earnings for its fourth quarter.
Via Benzinga · March 14, 2024
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Shares of HighPeak Energy, Inc. (NASDAQHPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Via Benzinga · March 7, 2024
ImmunoPrecise Antibodies (NASDAQ: IPA) Is Changing How We Look At The Complex World Of Antibody Discoverybenzinga.com
Even though we speak, listen, read and write every day, language is incredibly complex and ever-evolving. Context is critical to understanding. In the English language, there are a plethora of words that are spelled the same but have vastly different meanings depending on their context.
Via Benzinga · February 12, 2024
ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platformsbenzinga.com
ImmunoPrecise Antibodies (NASDAQIPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently
Via Benzinga · January 9, 2024
IPA Stock Earnings: ImmunoPrecise Antibodies Beats EPS, Beats Revenue for Q2 2024investorplace.com
IPA stock results show that ImmunoPrecise Antibodies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · December 14, 2023
Earnings Scheduled For December 14, 2023benzinga.com
Companies Reporting Before The Bell • Live Ventures (NASDAQLIVE) is estimated to report earnings for its fourth quarter. • Jabil NYSE:JBLNYSEJBL)
Via Benzinga · December 14, 2023
Gold Moves Higher; Campbell Soup Earnings Top Expectationsbenzinga.com
U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.
Via Benzinga · December 6, 2023